High-dose topotecan (90 and 180 μG) for recurrent subretinal and vitreous seeding in retinoblastoma
Purpose: To report on the use of intravitreal high-dose topotecan (90 and 180 μG) for recurrent subretinal and vitreous retinoblastoma, the toxicity of these injections, and the use of a 180-μG injection of intravitreal topotecan in humans. Observations: High-dose (90 and 180 μG) intravitreal topote...
Gespeichert in:
| Hauptverfasser: | , |
|---|---|
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
Elsevier
2025-12-01
|
| Schriftenreihe: | American Journal of Ophthalmology Case Reports |
| Schlagworte: | |
| Online-Zugang: | http://www.sciencedirect.com/science/article/pii/S2451993625001902 |
| Tags: |
Keine Tags, Fügen Sie das erste Tag hinzu!
|